Pandion Therapeutics Holdco

General Information


We are a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. We have combined a network-based conceptualization of the immune system with expertise in advanced protein engineering to develop our TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform. Our TALON platform enables us to employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network.

Employees: 43
Founded: 2016
Contact Information
Address 134 Coolidge Avenue, Watertown, MA 02472, US
Phone Number (617) 393-5925
Web Address
View Prospectus: Pandion Therapeutics Holdco
Financial Information
Market Cap $475.9mil
Revenues $2.97 mil (last 12 months)
Net Income $-27.0 mil (last 12 months)
IPO Profile
Symbol PAND
Exchange NASDAQ
Shares (millions): 7.5
Price range $18.00 - $18.00
Est. $ Volume $119.0 mil
Manager / Joint Managers Goldman Sachs/ Morgan Stanley/ SVB Leerink/ BMO Capital Markets
CO-Managers -
Expected To Trade: 7/17/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change